Trial Profile
An Open Label, Single Dose, Randomized 2-Way Crossover Study To Estimate The Relative Bioavailability Of Atorvastatin Commercial Tablet, And An Extemporaneous Preparation (Ep) Suspension Formulation, In Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Mar 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Atorvastatin
- Indications Hypercholesterolaemia
- Focus Pharmacokinetics
- Sponsors Pfizer
- 19 Feb 2009 New trial record